Home›Companies›Biotech & Pharma›Qentoros

Qentoros, Inc.

Develops peptide-based treatments for veterinarians treating joint infections in horses.

Updated Nov 9, 2026·Latest SEC filing Aug 28, 2026·Suggest an edit

About Qentoros

Qentoros is a private company based in Blacksburg, Virginia, incorporated in 2022 in Virginia. It has reported $605,000 raised in two offerings on Form D since February 2026. Its chief executive is Jessica Gilbertie.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 24, 2026Aug 28, 2026$505,000of $1.2M target9$56,111Options, Securities on exerciseRule 506(b)Form D ↗
Dec 17, 2025Feb 13, 2026amended Aug 28, 2026$100,000of $2.0M target2$50,000EquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$605,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Qentoros's Form D filed Aug 28, 2026.

MA
JS
John Schott
Director
Jessica Gilbertie
Jessica Gilbertie
Chief Executive Officer and director

Sources

  1. SECQENTOROS, INC Form D, filed Feb 13, 2026
  2. SECQENTOROS, INC filing history
  3. CompanyQentoros team